1. Zhang, R. -R., Salup, R. R., Urias, P. E., Twilley, T. A., Talmadge, J. E., Herbernan, R. B. and Wiltrout, R. H. (1986). Augmentation of NK activity and/ or macrophage-mediated cytotoxicity in the liver by biological response modifiers including human recombinant interleukin 2. Cancer lmmunol. lmmunother., 21, 19–25
2. Vose, B. M. and Moore, M. (1985). Human tumour-infiltrating lymphocytes: a marker of host response. Semin. Hematol., 22, 27–40
3. Ruco, L. P. and Meltzer, N. S. (1978). Macrophage activation for tumour cytotoxicity:development of macrophage cytotoxic activity requires completion of a sequence of shortlived intermediary reactions. J. lmmunol., 121, 2035–42
4. Kleinerman, E. S., Wiltrout, R. H., Zicht, R. and Fidler, I. H. (1985). Human lymphokine preparations which generate tumoricidal properties of human monocytes in vitro may be distinct from gamma interferon. Cancer Immunol. lmmunother., 20, 151–7
5. Gorelik, E., Wiltrout, R. H., Copeland, D. and Herberman, R. B. (1985). Modulation of formation of tumour metastases by peritoneal macrophages elicited by various agents. Cancer lmmunol. lmmunother., 19, 35–42